Annual report
4937.TEDINET S100PV1X
Period2021-10-01 → 2022-09-30
Filed2022-12-23
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 94
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.7bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥40m | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | −¥22m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥22m | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥57m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥57m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2022-09-30 | Cons. | Assets |
| Total liabilities | ¥821m | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥743m | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥801m | at 2021-09-30 | Cons. | Net assets |
| Cash and deposits | ¥906m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥906m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥169m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥176m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥129m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-19.04 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥246.98 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 47.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 44 | at 2022-09-30 | Cons. | Number of employees |
| Revenue | ¥2.7bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥4.7bn | 2020-10-01 → 2021-09-30 | Standalone | Net sales |
| Revenue | ¥4.5bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.4bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2017-10-01 → 2018-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | −¥40m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | ¥149m | 2020-10-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | −¥21m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥141m | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥109m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥794m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16m | 2017-10-01 → 2018-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥21m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥141m | 2020-10-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | −¥57m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥116m | 2020-10-01 → 2021-09-30 | Standalone | Profit loss |
| Net income | ¥99m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥795m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥22m | 2017-10-01 → 2018-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.6bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥1.9bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥1.2bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.0bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥781m | at 2018-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥820m | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥1.1bn | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥743m | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥801m | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥161m | at 2020-09-30d | Standalone | Net assets |
| Net assets / equity | ¥63m | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥311m | at 2018-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥905m | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2021-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2021-09-30 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥474m | at 2020-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥399m | at 2019-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥128m | 2020-10-01 → 2021-09-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥88m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥986m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥6m | 2020-10-01 → 2021-09-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥2m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥20m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥703m | 2020-10-01 → 2021-09-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥16m | 2019-10-01 → 2020-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥829m | 2018-10-01 → 2019-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-18.95 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.61 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.45 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-324.74 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.28 | 2017-10-01 → 2018-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40.9 | 2020-10-01 → 2021-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥247.07 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥266.72 | at 2021-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥59.61 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥23.16 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,408.3 | at 2018-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 47.5% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 13.7% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 6.3% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.9% | at 2018-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 24.1% | 2020-10-01 → 2021-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 88.1% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2017-10-01 → 2018-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,006,178 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,001,178 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,353,175 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 270,635 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 221,000 | at 2018-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 44 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 72 | at 2021-09-30 | Standalone | Number of employees |
| Employees | 59 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 55 | at 2019-09-30d | Standalone | Number of employees |
| Employees | 57 | at 2018-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 13
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-10-01 → 2022-09-30 | ¥1m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥319m |
| Direct To Consumer Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥5m |
| Direct To Consumer Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥2.5bn |
| Direct To Consumer Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥2.5bn |
| Direct To Consumer Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥123m |
| Medical Supportreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥200m |
| Medical Supportreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥200m |
| Medical Supportreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥156m |
| —segment total | depreciation | 2021-10-01 → 2022-09-30 | ¥5m |
| —segment total | revenue | 2021-10-01 → 2022-09-30 | ¥2.7bn |
| —segment total | revenue external | 2021-10-01 → 2022-09-30 | ¥2.7bn |
| —segment total | segment profit | 2021-10-01 → 2022-09-30 | ¥279m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 934
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)安藤 勇 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)新井 慎吾 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)棚卸資産（「商品」）の評価 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)【注記事項】(連結財務諸表作成のための基本となる重要な事項)重要な資産の評価基準及び評価方法 | |
| Reference2 kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)（重要な会計上の見積り） | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)関連当事者であるSBCメディカルグループ株式会社との取引 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)【関連当事者情報】 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)安藤 勇 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)新井 慎吾 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)棚卸資産（「商品」）の評価 | |
| Same as kam for consolidated fskam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row2Member | Original text (Japanese)関連当事者であるSBCメディカルグループ株式会社との取引 | |
| Same as kam for consolidated fskam non consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior4YearDuration | － | JPY |
| Net sales (5-year summary) | Prior3YearDuration | － | JPY |
| Net sales (5-year summary) | Prior2YearDuration | － | JPY |
| Net sales (5-year summary) | Prior1YearDuration | － | JPY |
| Net sales (5-year summary) | CurrentYearDuration | 2731376000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | － | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | － | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | － | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | － | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | -21640000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | － | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | － | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | － | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | － | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | -57156000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | － | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | － | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | － | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | － | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | -57156000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | － | JPY |
| Net assets (5-year summary) | Prior3YearInstant | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |